In a study partially funded by Medicine by Design, researchers have found that macrophages, a type of immune cell, play a crucial role in anti-cancer cell signaling within the brain’s protective membranes.
Valerie Wallace, co-director and senior scientist at the Donald K. Johnson Eye Institute, University Health Network (UHN), is the lead author of the study and a member of a Medicine by Design team project focused on enabling better outcomes in treating blindness.
This discovery offers potential insights into leveraging the body’s natural cancer-fighting processes to treat brain tumors. These findings can also be applied more broadly to creating effective immune cell therapies in regenerative medicine.